We are live on ! Find out more
CELU icon

Celularity

37 hedge funds and large institutions have $232M invested in Celularity in 2022 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,111% more capital inflows, than outflows

Capital inflows: $65.4M | Capital outflows: $5.4M

350% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 4

148% more call options, than puts

Call options by funds: $12.7M | Put options by funds: $5.13M

60% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 5

54% more funds holding

Funds holding: 24 → 37 (+13)

5.93% more ownership

Funds ownership: 13.54% → 19.48% (+5.9%)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

Holders
37
Holders Change
+13
Holders Change %
+54.17%
% of All Funds
0.58%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
18
Increased
8
Reduced
5
Closed
4
Calls
$12.7​M
Puts
$5.13​M
Net Calls
+$7.6​M
Net Calls Change
+$1.18​M

CELU Hedge Fund Activity: Q1 2022 in Review

37 of the 6,363 institutional investors tracked by Wall St. Rank reported a position in Celularity (CELU) for Q1 2022, worth a combined $232M — up 171% from $85.6M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new CELU positions and 4 closed out — a net gain of 14 holders — while 8 added to existing stakes and 5 trimmed.

The largest buyer was Starr International Company, adding an estimated $39.8M. The largest seller was Fidelity Investments, exiting entirely with an estimated $3.3M sold.

  • 37 institutional investors held Celularity (CELU) as of Q1 2022, up from 24 in Q4 2021.
  • Funds reported $232M of Celularity stock for Q1 2022, up 171% quarter-over-quarter.
  • 18 funds opened new Celularity positions in Q1 2022 and 4 closed out, a net change of +14 holders.
  • The largest Celularity buyer in Q1 2022 was Starr International Company, an estimated $39.8M added.
  • The largest Celularity seller in Q1 2022 was Fidelity Investments, an estimated $3.3M sold.

Based on aggregated 13F filings for Q1 2022.